Quest Diagnostics Incorporated (NYSE:DGX) Q1 2026 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics First Quarter 2026 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics Inc (DGX)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Antipodes Partners Jacob Mitchell | 162,589 | $31,864,192 | -6% | 0.61% |
| 2. | Leucadia National Ian Cumming And Joseph Steinberg | 33,473 | $6,560,038 | -19% | 0.04% |
| 3. | Ivy Lane Capital Robert W. Koehn | 29,000 | $5,683,420 | 8.59% | |
| 4. | Zevenbergen Capital Investments Nancy Zevenbergen | 11,075 | $2,170,479 | +7% | 0.06% |
| 5. | Arjuna Capital Farnum Brown And Adam Seitchik | 8,329 | $1,632,318 | -12% | 0.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.51 | 4,000 | $222,023.20 | 44,222 | 2014-05-05 | Filing | |
| $50.71 | 2,600 | $131,846.00 | 5,658 | 2014-02-06 | Filing | |
| $50.70 | 2,400 | $121,680.00 | 3,058 | 2014-02-06 | Filing | |
| $59.34 | 5,000 | $296,676.50 | 68,034 | 2012-08-07 | Filing | |
| $56.89 | 20,000 | $1,137,748.00 | 63,034 | 2012-05-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $206.21 | 5,558 | $1,146,115.18 | 67,122 | 2026-03-05 | Filing | |
| $206.21 | 3,878 | $799,682.38 | 37,557 | 2026-03-05 | Filing | |
| $206.21 | 2,855 | $588,729.55 | 15,198 | 2026-03-05 | Filing | |
| $204.86 | 2,628 | $538,372.08 | 13,441 | 2026-03-04 | Filing | |
| $207.73 | 632 | $131,285.36 | 67,122 | 2026-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,145,672 | $1,400,408,799 | 0.04% | |
| 2. | 6,081,400 | $1,191,832,772 | 0.06% | |
| 3. | 4,012,232 | $786,652,146 | 0.82% | |
| 4. | 1,949,535 | $382,085,386 | 0.08% | |
| 5. | 1,762,769 | $345,467,202 | 0.07% |
News See All
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript
Quest Diagnostics Incorporated (NYSE:DGX) Q4 2025 Earnings Call Transcript February 10, 2026Quest Diagnostics Incorporated misses on earnings expectations.
Quest Diagnostics Incorporated (DGX): A Bull Case Theory
We came across a bullish thesis on Quest Diagnostics Incorporated on Quality Value Investing’s Substack by David J. Waldron. In this article, we will summarize the bulls’ thesis on DGX.
Quest Diagnostics Incorporated (DGX): A Bull Case Theory
We came across a bullish thesis on Quest Diagnostics Incorporated on Valueinvestorsclub.com by cuyler1903. In this article, we will summarize the bulls’ thesis on DGX.
Quest Diagnostics Incorporated (NYSE:DGX) Q2 2025 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics second quarter 2025 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics (DGX) Develops MCaST Blood Test with MD Anderson Cancer Center
Quest Diagnostics Incorporated (NYSE:DGX) is one of the 7 most undervalued pot stocks to buy according to analysts.
7 Most Undervalued Pot Stocks To Buy According To Analysts
The global cannabis market was worth $26.86 billion in 2022, Spherical Insights & Consulting data shows. Three years later, Mordor Intelligence valued the market at $44.60 billion.
Quest Diagnostics Incorporated (NYSE:DGX) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Quest Diagnostics First Quarter 2025 Conference Call. At the request of the company, this call is being recorded.
Quest Diagnostics Incorporated (DGX): A Bull Case Theory
We came across a bullish thesis on Quest Diagnostics Incorporated (DGX) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on DGX.
Top 8 AI News Updates Investors Shouldn’t Miss
On March 19th, the stock market bounced back after the US Federal Reserve kept interest rates unchanged at 4.25% to 4.5%. The Fed also anticipated two rate cuts this year despite elevated inflation.
Hedge Fund Resource Center